|
Hyderabad, Jan 07: Bharat Biotech has completed enrollment of 25,800 volunteers for the Phase-3 trials of its COVID-19 vaccine Covaxin, Suchitra Ella, joint managing director, Bharat Biotech International Ltd said on Thursday.
In a message posted on the company”s Twitter account, she thanked clinical trial sites, principal investigators and health workers for their support and trust in the “public- private partnership” vaccine discovery.
Stop COVID vaccine misinformation campaigns: Harsh Vardhan to states
“My deep appreciation to all the volunteers for reposing and expressing Pro Vaccine Public Health Voluntarism in the phase-3 clinical trials of India”s 1st fully indigenous COVID-19 vaccine,”…
